Bio Ascend

A year-long mentorship and professional development program for early-career hematologists
A MISC 05451 Academy of Next Wave Investigators banner scaled

Academy of Next Wave of Investigators – Abstracts

Abstract submission guidelines  

Abstract text 

Word count: 700 (inclusive of title and abstract text) 
Font: Arial; Font Size: 11 
The suggested structure is outlined below; however, it is not required: 


Introduction, Methods, Results, Conclusions 
Multiple paragraphs are permitted. 
• Do not use bold or underline formatting; italics are permitted. 
• Use numerals to indicate numbers unless they are at the beginning of a sentence. 
• References are to be cited within the text, not as footnotes. 
• Figures and Tables are not included in the text count and must be uploaded as separate files. See below for file guidelines. 
• Please ensure any symbols are viewable and accurate after entering your abstract. 

Title

The title should objectively describe the study. 
• The title should be in sentence case. 
Please use generic rather than proprietary drug names. 
• Keep in mind, the title should not allude to a result or conclusion of the study. 

Abstract type 

All types of clinic-based and laboratory-based research projects relating to Chronic Lymphocytic Lymphoma (CLL) and Non-Hodgkin Lymphoma (NHL) are eligible for submission.
 

  • If a clinical trial, indicate if the trial has been registered, the registry, and the registration number.  
  • Figures and tables do not count towards the character count limit. 

Maximum file size is 10 MB and accepted formats are .jpg, .png, .pdf, and .doc  

 

We use cookies for various purposes including enabling website functionality and targeted marketing activities. For more information about cookies, please review our Privacy & Cookie Notice.